Short interest for Atlantica gives investors a sense of the degree to which investors are betting on the decline of Atlantica's stock. Short interest data is updated every two weeks.

Atlantica Stock (OTC:ALDA), Short Interest Report

ALDILA INC

Atlantica Inc is a shell company. It is seeking potential assets, property or businesses to acquire, in a business combination, by reorganization, merger or acquisition.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

ABUS

ACTG

ADAP

AIHS

AITX

ALDA

ANDE

ANGO

APEI

ARHVF

ASCK

ASMB

ASTC

Adtalem Global Education Inc. Common Stock

ATGE

AUUMF

AXTI

BARRF

BCII

BLFR

BLPG

BOMN

BOSSY

BRTX

BTLLF

BUHPF

BYZN

CANL

CARG

CBCA

CDTI

CELLCUBE ENERGY STORAGE by Cellcube Energy Storage Sys Inc.

CECBF

CEVE

CGHC

CGTFF

CHAP

CHKDG

CLDPQ

CLLS

CMCT

CMVLF

CNSNF

INTERNATIONAL COBALT ORD by International Cobalt Corp.

COBAF

COFE

CRSXF

CRUUF

CSGH

CTRA

CUKPF

CVET

DFMTF

DIIBF

DLNDY

DLOC

DMPI

DNOW

ECIFY

ECOS

ELOX

ENRFF

EPEG

ESGI

ESTR

EWLL

EZPW

FFXXF

FLSS

FRNKF

FTCH

FTPLF

FTXP

FUGMF

FURGF

FUTL

GALXF

GASE

GLGI

GOVX

GTCH

HTBX

HUNGF

IDLM

IHSI

IKNX

ILUS

INTV

IRNC

ITMMF

JDSHF

KALG

KALYTERA THERAPEUTICS ORD by Kalytera Therapeutics Inc.

KALTF

KALV

KNCAF

Stocks That Hit 52-Week Lows On Friday

Long Ideas

Short Ideas

Global

After-Hours Center

LTBR

SCON

 Benzinga&#39;s Small Cap Movers for Tuesday December 4, 2012

Alabama Dental Cartel Tried To Squash Competition

Atlantica Inc

BLEVF

CFXTF

CNVAF

CSQPF

DIISF

DREXF

IGPPF

IMMG

<p>Below are highlights from Benzinga's daily coverage of small cap securities making big moves:</p>

<p><b>Superconductor Technologies</b></p>

<p>Shares of Superconductor Technologies (NASDAQ: <a class="ticker" href="/stock/scon#NASDAQ">SCON</a>), the Austin, TX developer and producer of high temperature superconducting materials, rose 19% Tuesday on 21 times average volume.</p>

<p>Superconductor Technologies announced Tuesday the U.S. Patent and Trademark Office (USPTO) has issued a critical patent on STI's Reactive Co-Evaporation Cyclic Deposition and Reaction (RCE-CDR) device and method for fabricating HTS thin films for 2G HTS wire. The newly issued patent, U.S. Patent No. 8,290,553, is entitled "Device and Method for Fabricating Thin Films by Reactive Evaporation" and expires in 2025.</p>

<p>In addition, the European Patent Office recently indicated that it is prepared to grant a patent on STI's optimized composition of yttrium barium copper oxide (YBCO), expanding the US Patent 7,867,950 issued January 11, 2011.</p>

<p>Superconductor Technologies closed at $0.34 on Tuesday.</p>

<p><b>Lightbridge</b></p>

<p>Shares of Lightbridge (NASDAQ: <a class="ticker" href="/stock/ltbr#NASDAQ">LTBR</a>), the Tysons Corner, VA developer of proliferation resistant fuel technology, rose 12% Tuesday on higher than average volume.</p>

<p>Lightbridge announced Tuesday that corporate executives will present updates on Lightbridge operations, financial performance and strategic direction at two investor conferences on Wednesday, December 5, 2012.</p>

<p>At 8:15 AM ET, Seth Grae, Lightbridge President and Chief Executive Officer, will speak and answer questions at the RedChip Small-Cap Virtual Conference. At 6:30 PM ET, James P. Malone, Lightbridge Chief Nuclear Fuel Development Officer, will address the 5th Annual LDMicro Growth Conference in Los Angeles. </p>

<p>Lightbridge closed at $1.59 on Tuesday.</p>

<p><b>Aldila</b></p>

<p>Shares of Aldila (OTC: <a class="ticker" href="/stock/alda#OTC">ALDA</a>), the Poway, CA designer, manufacturer and marketer of carbon-based composite products and materials used in various end markets, rose 54% Tuesday on 45 times average volume.</p>

<p>Aldila announced Tuesday that it has signed a merger agreement with Mitsubishi Rayon America. The Merger Agreement provides that upon the effectiveness of the merger, Aldila's stockholders will receive cash consideration of $4.00 per share, representing a total purchase price of approximately $22 million for Aldila's common shares and a premium of 60% above Aldila's share price of $2.50 at the close of trading on December 3, 2012.</p>

<p>The Board has scheduled a stockholders meeting to be held on December 27, 2012, with a record date of November 21, 2012, for the stockholders to act on and approve the merger.</p>

<p>Aldila closed at $3.85 on Tuesday.</p>

<p><i>The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment.

Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.</i>
</p>

 Benzinga's Small Cap Movers for Tuesday December 4, 2012

Aldila Signs Merger Pact with Mitsubishi Rayon America; Aldila Holders to Get $4/Share in Deal

<p><span style="font-family: Georgia,"Times New Roman",serif;">The Nonprofit Quarterly (NPQ) has been following a controversy in Alabama involving a battle between the non-profit <a href="http://www.sarrelldental.org/">Sarrell Dental Center</a> and the state's for-profit, private "dental cartel" and its trade organization - the <a href="http://www.google.com/url?sa=t&amp;source=web&amp;cd=1&amp;sqi=2&amp;ved=0CCYQFjAA&amp;url=http%3A%2F%2Fwww.aldaonline.org%2F&amp;rct=j&amp;q=alabama%20dental%20association&amp;ei=IPAdTpKdKOaPsQKCleG5CA&amp;usg=AFQjCNHK0Ik5bPhyJKv45U59GG813gWXaQ&amp;sig2=G1WMTb0tc2hXHsw0xGHzPA&amp;cad=rja">Alabama Dental Association</a> (<a class="ticker" href="/stock/alda#">ALDA</a>), see news reports <a href="http://www.nonprofitquarterly.org/index.php?option=com_content&amp;view=article&amp;id=2187:nonprofit-newswire--alabama-nonprofit-vs-for-profit-dental-battle&amp;catid=155:daily-digest&amp;Itemid=986">here</a> (4/13/2010), <a href="http://www.nonprofitquarterly.org/index.php?option=com_content&amp;view=article&amp;id=11806:nonprofit-dental-clinic-in-alabama-generates-opposition-from-dentists-and-special-interests&amp;catid=155:nonprofit-newswire&amp;Itemid=986">here</a> (4/28/11) and <a href="http://www.nonprofitquarterly.org/index.php?option=com_content&amp;view=article&amp;id=13886:nonproit-dentistry-gathers-traction&amp;catid=155:nonprofit-newswire&amp;Itemid=986">here</a> (7/9/2011).  Here's some background:</span></p>
<p><span style="font-family: Georgia,"Times New Roman",serif;">From the clinic's website: "Sarrell Dental is a non-profit that treats the dental and optical needs  of Alabama children ages 1-20 with Medicaid or ALLKids insurance.   Sarrell Dental was founded in 2004 in Anniston, and since then Sarrell  has grown to include 11 other offices and it operates a mobile dental  bus which travels to schools and daycare centers throughout the state.  Since  2006, Sarrell has grown to include optical services in 5 of its  locations."</span><br />
<div style="font-family: Georgia,"Times New Roman",serif;"></div>
<div style="font-family: Georgia,"Times New Roman",serif;">From NPQ: "The clinic gave away  $400,000 in dental care to patients in 2010, never turns away a patient  even if they are late or don't have appointments, and, according to the  CEO, “If they make it here, somehow, somewhere, even if we have to stay  late, we'll see them.” </div>
<div style="font-family: Georgia,"Times New Roman",serif;"></div>
<div style="font-family: Georgia,"Times New Roman",serif;">The $10 million Sarrell  clinic, now the largest dental provider in the state, is turning away  job applicants and, according to the CEO, has “never had a complaint  from a consumer,” unlike other Medicaid specialty practices. There's no evidence – and no charges – that Sarrell is offering subpar  services."</div></p>

<div style="font-family: Georgia,"Times New Roman",serif;"></div>
<div style="font-family: Georgia,"Times New Roman",serif;"><b>MP:</b> So what's the problem? There really is none, unless you're a for-profit, private dentist and you don't welcome the competition from a non-profit organization.  In that case, you exercise your political  muscle and try to put your nonprofit competitor out of business, which the ALDA attempted to do, even though Sarrell was providing excellent, and sometime free, dental service to Alabama's under-served, poor children.  Sarrell countered with an anti-trust lawsuit against Alabama's dental cartel for trying to engage in monopolistic, anti-competitive behavior. </div>
<div style="font-family: Georgia,"Times New Roman",serif;"></div>
<div style="font-family: Georgia,"Times New Roman",serif;"><b>Bottom Line:</b> It now looks a <a href="http://www.sarrelldental.org/nonprofit-quarterly-%E2%80%93-lessons-from-the-victory">compromise has been reached</a>, signed by the governor, that will allow Sarrell to continue to operate under the supervision of the Alabama Board of Dental Examiners. In return, Sarrell will drop its antitrust lawsuit, although the FTC may still pursue action against the "dental cartel" for its attempts to put its non-profit competition out of business. </div>
<p><span style="font-family: Georgia,"Times New Roman",serif;"></span><span style="font-family: Georgia,"Times New Roman",serif;"></span><br />
<div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/28997633-5757246377003180437?l=mjperry.blogspot.com' alt='' /></div>
</p>

<p>VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 7, 2009) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCBB:APCSF) ("the Company" or "ALDA") announces that, in tests conducted at an independent laboratory in the US, T36(R) Antiseptic Hand Sanitizer has been shown to completely kill the new H1N1 Virus (Swine-like H1N1 Influenza A virus Strain A/California/04/2009) in 15 seconds or less.</p>
<p>Dr. Terrance Owen, President &amp; CEO states, "Since the first outbreak of the new H1N1 virus strain in Mexico in March of this year, the World Health Organization (WHO) has been warning that this particular strain of the virus could cause a global pandemic. By early June, the virus had reached all six WHO regions with nearly 30,000 confirmed cases reported in 74 countries. On June 11, 2009, the WHO raised its global pandemic alert level to "Level Six", the highest level possible, for the first time since 1968. A Level Six pandemic means that a virus is spreading widely in at least two of the six WHO regions. The Vancouver Organizing Committee for the 2010 Olympic and Paralympic Winter Games ("VANOC") is committed to providing a safe environment for people from all over the world to come and participate and observe the Games. We decided to test T36(R) Antiseptic Hand Sanitizer against this new strain of H1N1 that is the subject of the pandemic warning and are pleased that it has proven to be very effective. We look forward to providing T36(R) Antiseptic Hand Sanitizer to help protect people who are coming to Vancouver in 2010 and doing our part to contribute to the success of the Games".</p>
<p>About ALDA Pharmaceuticals Corp.</p>
<p>ALDA is focused on the development of infection-control therapeutics derived from its patented T36(R) technology. The company trades on the TSX Venture Exchange under the symbol APH and on the OTCBB under the symbol APCSF. The Company is an Official Supplier of the 2010 Olympic Winter Games, 2010 Paralympic Winter Games, Canadian Olympic Committee, 2010 Canadian Olympic Team and 2012 Canadian Olympic Team for antiseptic hand sanitizer, disinfectant and disinfectant cleaning products.</p>
<p>Terrance G. Owen, Ph.D., MBA, President &amp; CEO </p>
<p>ALDA Pharmaceuticals Corp.</p>
<p>Cautionary Note Regarding Forward-looking Statements: Information in this press release that involves ALDA's expectations, plans, intentions or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. ALDA generally uses words such as "outlook", "will", "could", "would", "might", "remains", "to be", "plans", "believes", "may", "expects", "intends", "anticipates", "estimate", "future", "plan", "positioned", "potential", "project", "remain", "scheduled", "set to", "subject to", "upcoming", and similar expressions to help identify forward-looking statements. The forward-looking statements in this release are based upon information available to ALDA as of the date of this release, and ALDA assumes no obligation to update any such forward-looking statements. Forward-looking statements believed to be true when made may ultimately prove to be incorrect. These statements are not guarantees of the future performance of ALDA and are subject to risks, uncertainties and other factors, some of which are beyond its control and may cause actual results to differ materially from current expectations.</p>


ALDA's T36(R) Antiseptic Hand Sanitizer Kills 2009 H1N1 Flu (Swine Flu) Virus in 15 Seconds

Atlantica

ticker ▲▼	Name ▲▼	Effective Date ▲▼	% of Float Shorted ▲▼	Float ▲▼	Short Interest ▲▼	Volume ▲▼	Days to Cover ▲▼	Get Alert
ALDA	Atlantica, Inc. Common Stock	08/09/2022	0.03%	67,790	17	—	999.99	Get Alert
ALDA	Atlantica, Inc. Common Stock	07/26/2022	0.03%	67,790	17	121	1	Get Alert